Fiera Capital Corp Acquires 3,846 Shares of Stryker Corporation (NYSE:SYK)

Fiera Capital Corp increased its holdings in Stryker Corporation (NYSE:SYK - Free Report) by 17.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,233 shares of the medical technology company's stock after acquiring an additional 3,846 shares during the period. Fiera Capital Corp's holdings in Stryker were worth $9,765,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Elefante Mark B bought a new position in shares of Stryker in the fourth quarter worth $337,000. Mogy Joel R Investment Counsel Inc. increased its holdings in shares of Stryker by 3.4% in the first quarter. Mogy Joel R Investment Counsel Inc. now owns 98,216 shares of the medical technology company's stock worth $36,561,000 after purchasing an additional 3,218 shares during the period. Ferguson Wellman Capital Management Inc. increased its holdings in shares of Stryker by 1.9% in the first quarter. Ferguson Wellman Capital Management Inc. now owns 174,871 shares of the medical technology company's stock worth $65,096,000 after purchasing an additional 3,341 shares during the period. Harbor Capital Advisors Inc. bought a new position in shares of Stryker in the first quarter worth $1,840,000. Finally, Mar Vista Investment Partners LLC increased its holdings in shares of Stryker by 10.2% in the first quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company's stock worth $33,572,000 after purchasing an additional 8,353 shares during the period. 77.09% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on SYK. Roth Mkm increased their target price on Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research note on Friday, May 2nd. Sanford C. Bernstein set a $450.00 price objective on shares of Stryker in a report on Monday, May 5th. Citigroup reaffirmed a "buy" rating and set a $455.00 target price (up previously from $443.00) on shares of Stryker in a research note on Thursday, May 22nd. Wall Street Zen raised shares of Stryker from a "hold" rating to a "buy" rating in a research note on Friday, July 18th. Finally, BTIG Research reaffirmed a "buy" rating on shares of Stryker in a research note on Monday, July 14th. Four analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $428.55.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director directly owned 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 5.90% of the company's stock.

Stryker Trading Up 0.1%

NYSE:SYK traded up $0.24 during mid-day trading on Wednesday, hitting $400.81. 1,077,201 shares of the stock traded hands, compared to its average volume of 1,068,540. The stock has a market capitalization of $152.99 billion, a price-to-earnings ratio of 54.16, a PEG ratio of 2.97 and a beta of 0.91. Stryker Corporation has a 52 week low of $314.93 and a 52 week high of $406.19. The firm's 50 day moving average is $387.13 and its two-hundred day moving average is $379.97. The company has a quick ratio of 1.00, a current ratio of 1.64 and a debt-to-equity ratio of 0.69.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating the consensus estimate of $2.73 by $0.11. The company had revenue of $5.87 billion for the quarter, compared to the consensus estimate of $5.68 billion. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The firm's revenue was up 11.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.50 EPS. On average, equities research analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Monday, June 30th. Stryker's dividend payout ratio (DPR) is presently 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.